More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the ...

New research highlights progress in treating age-related macular degeneration, including late‑stage drug trials, gene therapy strategies, and a wireless retinal prosthesis that restored limited ...

Following the successful late-stage study in wet age-related macular degeneration, Ocular plans to meet with the FDA to ...

Throughout February, @HopkinsMedicine experts from the Wilmer Eye Institute are available to discuss prevention and ...

Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, ...

WAUSAU, Wis. (WSAW) - Geographic atrophy affects approximately one million people in the United States and is commonly associated with both dry and wet macular degeneration. Now a new treatment is ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Ocular Therapeutix said it would release topline data from its Phase 3 superiority clinical trial of its Axpaxli treatment of wet age-related macular degeneration on Tuesday. Detailed data will be ...

According to the National Eye Institute, age-related macular degeneration impacts 11 million adults in the U.S. every year. Characterized by a loss of the vision needed to see straight ahead and by ...

Share on Pinterest The FDA has approved biosimilars for macular degeneration treatment. recep-bg/Getty Images The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related ...

Larry Hoffheimer watched helplessly as his mother, Florence, went from doctor to doctor seeking better glasses more than 20 years ago. Getting a diagnosis of macular degeneration didn’t resolve the ...